Aurobindo Pharma fundamental analysis
AUROPHARMA
1187
13.10 (-1.09%)Last updated on 31 Dec, 2025 | 12:26 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Aurobindo Pharma Fundamentals
P/E Ratio
20.15
P/B Ratio
1.97
Div. Yield
0
Sector P/E
69.6
Sector P/B
1.05
Sec. Div. Yield
0.56
Aurobindo Pharma Fundamentals is currently trading with a P/E Ratio of 20.15, compared to the sector average of 69.6. Its P/B Ratio stands at 1.97, while the sector’s is 1.05. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.
Aurobindo Pharma Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Average
On its scorecard, Aurobindo Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
